ImageneBio (IMA) Current Assets (2020 - 2024)
Historic Current Assets for ImageneBio (IMA) over the last 5 years, with Q3 2024 value amounting to $141.5 million.
- ImageneBio's Current Assets fell 2945.71% to $141.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $141.5 million, marking a year-over-year decrease of 2945.71%. This contributed to the annual value of $178.7 million for FY2023, which is 1165.68% up from last year.
- ImageneBio's Current Assets amounted to $141.5 million in Q3 2024, which was down 2945.71% from $149.3 million recorded in Q2 2024.
- ImageneBio's 5-year Current Assets high stood at $283.2 million for Q1 2021, and its period low was $141.2 million during Q1 2023.
- Its 5-year average for Current Assets is $193.3 million, with a median of $178.3 million in 2022.
- Per our database at Business Quant, ImageneBio's Current Assets skyrocketed by 4250.61% in 2021 and then tumbled by 3465.49% in 2023.
- Quarter analysis of 5 years shows ImageneBio's Current Assets stood at $166.0 million in 2020, then soared by 42.51% to $236.5 million in 2021, then plummeted by 32.35% to $160.0 million in 2022, then grew by 11.66% to $178.7 million in 2023, then dropped by 20.78% to $141.5 million in 2024.
- Its Current Assets was $141.5 million in Q3 2024, compared to $149.3 million in Q2 2024 and $161.2 million in Q1 2024.